IBSA Choriomon 1 vial (1x 5000 IU)

HCG – human chorionic gonadotropin – Pregnyl

This non-steroid medication is increasingly popular among athletes. HCG is a natural protein hormone produced by the human placenta and derived from the urine of pregnant women. While not a male hormone, it closely mimics LH (Luetinising Hormone), effectively stimulating testosterone production in males. This property allows HCG to support athletes in restoring natural testosterone levels often suppressed by prolonged steroid use. Furthermore, high-dose steroids can artificially signal the hypothalamus, potentially leading to reduced testicular response and atrophy. To mitigate this, athletes utilize HCG to sustain testicular function. Upon injection, HCG elevates serum testosterone levels rapidly—a noticeable increase occurs within two hours, with a second peak emerging two to four days later. HCG therapy effectively prevents testicular atrophy while harnessing the body’s natural hormone production during training. Users often report significant strength and size enhancements when combining HCG with steroids because of the concurrent presence of natural and synthetic androgens. Although no definitive dosage has been established, many athletes opt for weekly doses of 1000-2000 IU, limiting cycles to three weeks with at least a month off between treatments. It is commonly suggested to integrate HCG in the middle or towards the end of a steroid cycle. Prolonged HCG usage might hinder the body’s production of gonadotropins, necessitating short cycles to prevent long-term suppression. Side effects can include gynecomastia, water retention, increased libido, mood changes, headaches, and elevated blood pressure. HCG can raise male androgen levels significantly (up to 400%), which concurrently elevates estrogen, leading to potential gynecomastia. Users may also experience nausea akin to morning sickness. There are no recorded overdose incidents with HCG, nor links to cancer, liver, or kidney impairment. Initial research speculated about its potential to carry the AIDS virus, but these claims have been debunked. Athletes often utilize HCG as a safe alternative during steroid cycles to evade adverse cessation effects, and it remains undetectable in steroid tests, making it a strategic option leading up to competitions with drug screenings. After mixing, HCG requires refrigeration, remaining effective for around 10 weeks and is administered intramuscularly, typically prescribed for hypogonadism.

Pregnyl for Pregnancy:

Pregnyl, or human chorionic gonadotropin (hCG), is a refined solution obtained from the urine of pregnant individuals. Delivered intramuscularly, it emulates the typical mid-cycle LH surge, prompting ovulation. Optimal results occur with daily intercourse for the 48 hours following ovulation. Your healthcare provider will guide optimal timing for intercourse or when to proceed with artificial insemination to maximize pregnancy chances.

How are Humegon and Pregnyl Administered?

Humegon is given via intramuscular injection, usually in the buttocks, as it cannot be taken orally due to its protein structure. Injections commence within the first 5 days of the menstrual cycle, often daily for 7 to 12 days. Dosages and schedules can vary based on individual responses. Pregnyl is administered intramuscularly when specific response criteria are met; in cases of excessive responses, injections may be postponed.

Length of Treatment

If conception does not occur, Humegon and Pregnyl treatments may repeat in subsequent menstrual cycles but are often not consecutive as therapeutic plans are tailored to each individual. Treatment may extend for up to six cycles, after which alternative options are discussed.

Is It Working?

Confirmation of ovulation occurs when the ovary produces the hormone progesterone, measurable via blood tests around 7 days post-ovulation. If pregnancy does not happen, menstruation typically follows 14 days after the hCG injection. Absence of a period warrants a pregnancy test, with ultrasound supporting pregnancy monitoring.

Careful Monitoring is Important

Regular monitoring ensures effective treatment and minimizes side effects. This is commonly achieved through daily blood tests measuring estrogen levels correlated with follicular development. An increase in estrogen signals enhanced ovarian response to Humegon. Ultrasound can visualize ovarian follicles, aiding in estimating ovulation timing. Attending all scheduled tests is crucial for appropriate treatment adjustments.

Side Effects/Other Concerns Associated with Treatment

Treatments with Humegon and Pregnyl may lead to various side effects, ranging from mild to severe. Injection site irritation and pain, headaches, abdominal discomfort, and ovarian enlargement are common. It’s essential to communicate any adverse reactions to your doctor, who may adjust your treatment accordingly. Furthermore, Pregnyl can also cause injection site pain, headaches, mood changes, fatigue, and unilateral swelling due to fluid retention. There is a risk of multiple pregnancies with fertility drugs like Humegon and Pregnyl; about 80% of pregnancies result in singleton births, with twins being the most common among multiple births. Your physician should discuss these risks before commencing treatment. Always consult your physician regarding any side effects or concerns before beginning therapy.

How Effective is Humegon (Menotropins for Injection, USP)?

Humegon can successfully induce ovulation in individuals with irregular cycles or those who do not ovulate. Its effectiveness varies according to underlying causes of infertility, with factors such as tubal status, sperm quality, and age being critical in achieving pregnancy. If outcomes fall short while using Humegon, further options will be discussed with your provider.

Conclusion

Many healthy babies are welcomed into the world due to fertility treatments with agents like Humegon and Pregnyl (chorionic gonadotropin for injection, USP). For further inquiries regarding these medications, consult your doctor.